| 书目名称 | Molecular Diagnosis of Cancer | | 副标题 | Methods and Protocol | | 编辑 | Joseph E. Roulston,John M. S. Bartlett | | 视频video | | | 概述 | Includes supplementary material: | | 丛书名称 | Methods in Molecular Medicine | | 图书封面 |  | | 描述 | We are currently experiencing a fundamental shift in the way in which we approach the characterization of cancer. Never before has the make up of cancer tissues and individual cells been so exhaustively researched and char- terized. We are now capable of producing molecular “fingerprints” that ch- acterize the expression of all known and unknown genes within tumors and their surrounding tissues. More than 30,000 different genes may be measured in each patient’s tumor in a single experiment. Simultaneously, novel therapies that exploit the molecular roadmap have been developed and are now being offered to patients. These novel agents, such as Glivec, Herceptin, Iressa, and others, specifically target individual genes within tumors and can produce d- matic responses in some patients. These drugs are only the forerunners of a coming tidal wave of novel therapeutics that individually target specific m- ecules within cancer cells—more than 300 such agents are currently in phase I or II clinical trials. This is an exciting time for cancer specialists and patients alike. However, if we have learned anything from the past 50 or more years of research into cancer, it is that Lord Beaverbroo | | 出版日期 | Book 2004Latest edition | | 版次 | 2 | | doi | https://doi.org/10.1385/1592597602 | | isbn_softcover | 978-1-61737-396-1 | | isbn_ebook | 978-1-59259-760-4Series ISSN 1543-1894 Series E-ISSN 1940-6037 | | issn_series | 1543-1894 | | copyright | Humana Press 2004 |
The information of publication is updating
|
|
发表于 2025-3-21 19:28:02
